Your browser doesn't support javascript.
loading
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of
Acta Pharmaceutica Sinica B ; (6): 925-940, 2021.
Article Dans Anglais | WPRIM | ID: wpr-881177
ABSTRACT
The management of the central nervous system (CNS) disorders is challenging, due to the need of drugs to cross the bloodbrain barrier (BBB) and reach the brain. Among the various strategies that have been studied to circumvent this challenge, the use of the intranasal route to transport drugs from the nose directly to the brain has been showing promising results. In addition, the encapsulation of the drugs in lipid-based nanocarriers, such as solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs) or nanoemulsions (NEs), can improve nose-to-brain transport by increasing the bioavailability and site-specific delivery. This review provides the state-of-the-art of

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Anglais Texte intégral: Acta Pharmaceutica Sinica B Année: 2021 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Anglais Texte intégral: Acta Pharmaceutica Sinica B Année: 2021 Type: Article